Department of Surgery, San Giovanni di Dio Hospital, Via Fatebenefratelli 34, 34170, Gorizia, Italy.
Department of Surgery, Cattinara Hospital, Strada di Fiume 447, 34149, Trieste, Italy.
Obes Surg. 2019 Oct;29(10):3133-3141. doi: 10.1007/s11695-019-03962-w.
Enhanced Recovery After Surgery (ERAS) pathways have been shown to improve postoperative outcomes. However, its application in bariatric surgery is still limited. The aim of the study was to define the safety of ERAS in bariatric patients with regard to postoperative complications, length of hospital stay (LOS), and readmission rates within 30 days from surgery.
The effectiveness and safety of an ERAS protocol was prospectively investigated in morbidly obese patients who underwent bariatric surgery in a single-institute experience over a 2-year period.
Between June 2016 and September 2018, a total of 89 laparoscopic sleeve gastrectomy (SG), 105 Roux-en-Y gastric bypass (RYGB), and 8 one-anastomosis gastric bypass (OAGB) were performed. Twenty patients (9.9%) were revisional cases. Mean (standard deviation, SD) BMI and age at time of surgery were 43.2 (± 6.2) kg/m and 46 (± 11.3) years, respectively. Median (range) surgical time was 118 (45-255) minutes. Overall postoperative complication rate was 7.4%, with 6 (3.0%) patients developing grade III-IV complications according to the Clavien-Dindo classification. Median (range) LOS was 2 (1-50) days, with mean (SD) LOS of 2.3 (± 3.6) days. Overall, 36.6% of patients were discharged by first postoperative day and 77.7% by second postoperative day. Readmission rate was 4.5%. No mortality was observed during the study period.
According to the results of the present study, ERAS in primary and revisional bariatric surgery is safe and feasible, with short LOS, low morbidity and readmission rates, and no mortality. A significant reduction of mean LOS was progressively noted over the study period.
加速康复外科(ERAS)方案已被证明可改善术后结果。然而,其在减重手术中的应用仍然有限。本研究旨在确定 ERAS 在接受减重手术的肥胖患者中的安全性,具体涉及术后并发症、住院时间(LOS)和术后 30 天内的再入院率。
在单中心经验中,前瞻性研究了肥胖患者在 2 年内接受减重手术的 ERAS 方案的有效性和安全性。
2016 年 6 月至 2018 年 9 月,共完成 89 例腹腔镜袖状胃切除术(SG)、105 例 Roux-en-Y 胃旁路术(RYGB)和 8 例单吻合口胃旁路术(OAGB)。20 例(9.9%)为翻修手术。手术时平均(标准差,SD)BMI 和年龄分别为 43.2(±6.2)kg/m2和 46(±11.3)岁。中位(范围)手术时间为 118(45-255)分钟。总体术后并发症发生率为 7.4%,根据 Clavien-Dindo 分类,有 6 例(3.0%)患者发生 III-IV 级并发症。中位(范围) LOS 为 2(1-50)天,平均(SD) LOS 为 2.3(±3.6)天。总体而言,有 36.6%的患者在术后第 1 天出院,77.7%的患者在术后第 2 天出院。再入院率为 4.5%。研究期间无死亡。
根据本研究结果,原发性和翻修性减重手术中的 ERAS 是安全且可行的,具有较短的 LOS、较低的发病率和再入院率,且无死亡率。在研究期间,平均 LOS 显著缩短。